Original Research

Published on 19 Jun 2023

Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology

in Cardiovascular and Smooth Muscle Pharmacology

Yunfeng Yu
Manli Zhou
Xi Long
Shuang Yin
Gang Hu
Xinyu Yang
Weixiong Jian
Rong Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1147360

4,627 views
4 citations

Review

Published on 15 Jun 2023

Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension

in Cardiovascular and Smooth Muscle Pharmacology

Xiaolin Liao
Yuanshan Han
Ying He
Jianjun Liu
Yuhong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209890

3,566 views
2 citations

Original Research

Published on 13 Jun 2023

Increased plasma renin by vasodilators promotes the progression of abdominal aortic aneurysm

in Cardiovascular and Smooth Muscle Pharmacology

Yu Liu
Shuai Liu
Jiani Zhao
Kemin Wu
Baohui Xu
Wei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1174278

3,125 views
1 citation

Case Report

Published on 13 Jun 2023

Central retinal vein occlusion with cerebral infarction secondary to anlotinib treatment: a case report and literature review

in Cardiovascular and Smooth Muscle Pharmacology

Yingying Chen
Yi Du
Lu Qiu
Jing Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188218

1,929 views
1 citation

Editorial

Published on 13 Jun 2023

Editorial: Targeting inflammation to prevent complications in stroke

in Cardiovascular and Smooth Muscle Pharmacology

Lourdes M. Varela
Elena Meseguer
Almudena Ortega-Gómez

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1229303

1,092 views

Original Research

Published on 12 Jun 2023

Protective effect of cafestol against doxorubicin-induced cardiotoxicity in rats by activating the Nrf2 pathway

in Cardiovascular and Smooth Muscle Pharmacology

Sara A. Al-Kenany
Nada N. Al-Shawi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1206782

3,214 views
17 citations

Original Research

Published on 09 Jun 2023

Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

in Cardiovascular and Smooth Muscle Pharmacology

Marco Mele
Paola Imbrici
Antonietta Mele
Maria Vittoria Togo
Giorgia Dinoi
Michele Correale
Natale Daniele Brunetti
Orazio Nicolotti
Annamaria De Luca
Cosimo Damiano Altomare

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1175606

2,144 views
5 citations

Original Research

Published on 30 May 2023

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors

in Cardiovascular and Smooth Muscle Pharmacology

Lukas Fiedler
Lukas J. Motloch
Anna-Maria Dieplinger
Peter Jirak
Paruir Davtyan
Diana Gareeva
Elena Badykova
Marat Badykov
Irina Lakman
Aleksandr Agapitov

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1093396

2,381 views

Original Research

Published on 30 May 2023

Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1

in Cardiovascular and Smooth Muscle Pharmacology

Shuai Wang
Jie Bai
Yilin Che
Weikun Qu
Jing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164333

2,488 views
3 citations

Review

Published on 25 May 2023

Drug therapy for myocarditis induced by immune checkpoint inhibitors

in Cardiovascular and Smooth Muscle Pharmacology

Yihao Wu
Yizhou Xu
Linhao Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161243

7,214 views
5 citations

Original Research

Published on 23 May 2023

Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice

in Cardiovascular and Smooth Muscle Pharmacology

Fangze Huang
Ximao Liu
Junjie Liu
Yu Xie
Li Zhao
Deshen Liu
Zifeng Zeng
Xiu Liu
Shaoyi Zheng
Zezhou Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1148410

2,835 views
7 citations

Original Research

Published on 17 May 2023

A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model

in Cardiovascular and Smooth Muscle Pharmacology

Shuai Teng
Zhaowei Zhu
Yang Li
Xinqun Hu
Zhenfei Fang
Zhenjiang Liu
Shenghua Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1159779

1,556 views
2 citations

Original Research

Published on 12 May 2023

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system

in Cardiovascular and Smooth Muscle Pharmacology

Feifei Wang
Bingfeng Zhou
Hongwei Sun
Xinan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170039

3,319 views
7 citations

Review

Published on 05 May 2023

Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Shuangcui Wang
Yuli Wang
Yun Deng
Jiaqi Zhang
Xijuan Jiang
Jianchun Yu
Jiali Gan
Wenyun Zeng
Maojuan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1167260

3,812 views
4 citations

Original Research

Published on 05 May 2023

Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices

in Cardiovascular and Smooth Muscle Pharmacology

Qin Wu
Abigail J. Ross
Tugce Ipek
Georgina H. Thompson
Robert D. Johnson
Changhao Wu
Patrizia Camelliti

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1127388

2,309 views
1 citation

Original Research

Published on 25 Apr 2023

Trends and characteristics of COVID-19 and cardiovascular disease related studies

in Cardiovascular and Smooth Muscle Pharmacology

Ao Cheng
Honghao Ren
Zeyao Ma
Naqash Alam
Linying Jia
Enqi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1105459

1,996 views
5 citations

Navigation group

Articles

Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology

Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension

Increased plasma renin by vasodilators promotes the progression of abdominal aortic aneurysm

Central retinal vein occlusion with cerebral infarction secondary to anlotinib treatment: a case report and literature review

Editorial: Targeting inflammation to prevent complications in stroke

Protective effect of cafestol against doxorubicin-induced cardiotoxicity in rats by activating the Nrf2 pathway

Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors

Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1

Drug therapy for myocarditis induced by immune checkpoint inhibitors

Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice

A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system

Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome

Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices

Trends and characteristics of COVID-19 and cardiovascular disease related studies